Compare FWDI & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FWDI | DNA |
|---|---|---|
| Founded | 1961 | 2008 |
| Country | United States | United States |
| Employees | 60 | 485 |
| Industry | Plastic Products | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 423.2M | 455.8M |
| IPO Year | N/A | N/A |
| Metric | FWDI | DNA |
|---|---|---|
| Price | $4.14 | $8.12 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | 1.0M | ★ 1.3M |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $407.02 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.62 | $5.37 |
| 52 Week High | $9.28 | $17.58 |
| Indicator | FWDI | DNA |
|---|---|---|
| Relative Strength Index (RSI) | 44.24 | 45.41 |
| Support Level | $4.09 | $7.59 |
| Resistance Level | $5.04 | $10.21 |
| Average True Range (ATR) | 0.32 | 0.74 |
| MACD | -0.07 | -0.07 |
| Stochastic Oscillator | 35.21 | 28.13 |
Forward Industries Inc is a provider of carrying and protective solutions. The company operates in two segments: design and digital assets. The design segment consists of two operating segments (IPS and Kablooe, which have been aggregated into one reportable segment) that provide a full spectrum of hardware and software product design and engineering services to customers predominantly.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.